Effect of gender on outcomes following radical cystectomy for urothelial carcinoma of the bladder: A critical analysis of 1,994 patients

Urologic Oncology: Seminars and Original Investigations

Volumn 32, Issue 1, 2014, Pages 52.e1-52.e9

  Mitra, Anirban P ^a,b   Skinner, Eila C ^c   Schuckman, Anne K ^a   Quinn, David I ^a   Dorff, Tanya B ^a   Daneshmand, Siamak ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c STANFORD UNIVERSITY   (United States)

Author keywords

Bladder cancer; Case control studies; Female; Prognosis

Indexed keywords

PROTEIN P53;

ADJUVANT CHEMOTHERAPY; AGED; ARTICLE; BLADDER CARCINOMA; CANCER PROGNOSIS; CANCER SPECIFIC SURVIVAL; CANCER STAGING; CONTROLLED STUDY; CYSTECTOMY; DEMOGRAPHY; FEMALE; FOLLOW UP; GENDER; HUMAN; HYDRONEPHROSIS; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RECURRENCE FREE SURVIVAL; TRANSITIONAL CELL CARCINOMA; TREATMENT OUTCOME; UNIVARIATE ANALYSIS;

BLADDER CANCER; CASE-CONTROL STUDIES; FEMALE; PROGNOSIS;

AGED; CARCINOMA, TRANSITIONAL CELL; CASE-CONTROL STUDIES; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; CYSTECTOMY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; OUTCOME ASSESSMENT (HEALTH CARE); PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SEX FACTORS; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 84890786885     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2013.08.007     Document Type: Article

References (30)

1. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA Cancer J Clin 2011, 61:69-90.
2. Lee R., Droller M.J. The natural history of bladder cancer. Implications for therapy. Urol Clin North Am 2000, 27:1-13.
3. Aben K.K., Kiemeney L.A. Epidemiology of bladder cancer. Eur Urol 1999, 36:660-672.
4. Madeb R., Messing E.M. Gender, racial, and age differences in bladder cancer incidence and mortality. Urol Oncol 2004, 22:86-92.
5. Zehnder P., Studer U.E., Skinner E.C., et al. Unaltered oncological outcomes of radical cystectomy with extended lymphadenectomy over three decades. BJU Int 2013, 112:E51-E58.
6. Mitra A.P., Cote R.J. Molecular screening for bladder cancer: progress and potential. Nat Rev Urol 2010, 7:11-20.
7. Shariat S.F., Sfakianos J.P., Droller M.J., Karakiewicz P.I., Meryn S., Bochner B.H. The effect of age and gender on bladder cancer: a critical review of the literature. BJU Int 2010, 105:300-308.
8. Horstmann M., Witthuhn R., Falk M., Stenzl A. Gender-specific differences in bladder cancer: a retrospective analysis. Gend Med 2008, 5:385-394.
9. Tuygun C., Kankaya D., Imamoglu A., et al. Sex-specific hormone receptors in urothelial carcinomas of the human urinary bladder: a comparative analysis of clinicopathological features and survival outcomes according to receptor expression. Urol Oncol 2011, 29:43-51.
10. Mungan N.A., Aben K.K., Schoenberg M.P., et al. Gender differences in stage-adjusted bladder cancer survival. Urology 2000, 55:876-880.
11. Tracey E., Roder D., Luke C., Bishop J. Bladder cancer survivals in New South Wales, Australia: why do women have poorer survival than men?. BJU Int 2009, 104:498-504.
12. Mungan N.A., Kiemeney L.A., van Dijck J.A., van der Poel H.G., Witjes J.A. Gender differences in stage distribution of bladder cancer. Urology 2000, 55:368-371.
13. Jeldres C., Isbarn H., Capitanio U., et al. Gender is an important predictor of cancer-specific survival in patient with transitional cell carcinoma after radical cystectomy. J Urol 2009, 181(Suppl.):e635. [abstr].
14. Bianchi M., Sun M., Trinh Q.D., et al. Gender differences in patients with bladder cancer treated with radical cystectomy: a population-based analysis. J Urol 2012, 187(Suppl.):e646. [abstr].
15. Fajkovic H., Halpern J.A., Cha E.K., et al. Impact of gender on bladder cancer incidence, staging, and prognosis. World J Urol 2011, 29:457-463.
16. Stein J.P., Lieskovsky G., Cote R., et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 2001, 19:666-675.
17. Pasin E., Josephson D.Y., Mitra A.P., Cote R.J., Stein J.P. Superficial bladder cancer: an update on etiology, molecular development, classification, and natural history. Rev Urol 2008, 10:31-43.
18. Urinary bladder. In: Greene FL, Page DL, Fleming ID, et al., editors. AJCC Cancer Staging Manual, ed. 6. New York: Springer-Verlag, 2002. pp. 335-40.
19. Mostofi F.K., Sobin H.L., Torlini H. Histologic Typing of Urinary Bladder Tumors 1973, World Health Organization, Geneva.
20. Rosenbaum P.R. Optimal matching for observational studies. J Am Stat Assoc 1989, 84:1024-1032.
21. Howlader N., Noone A.M., Krapcho M., et al. SEER Cancer Statistics Review, 1975-2009 (Vintage 2009 Populations) 2012, National Cancer Institute, Bethesda.
22. Svatek R.S., Shariat S.F., Dinney C.P., et al. Evidence-based gender related outcomes after radical cystectomy: results of a large multicenter study. J Urol 2009, 181(Suppl.):e629. [abstr].
23. Kalish L.A., Harrington D.P. Efficiency of balanced treatment allocation for survival analysis. Biometrics 1988, 44:815-821.
24. Scosyrev E., Noyes K., Feng C., Messing E. Sex and racial differences in bladder cancer presentation and mortality in the US. Cancer 2009, 115:68-74.
25. Mallin K., David K.A., Carroll P.R., Milowsky M.I., Nanus D.M. Transitional cell carcinoma of the bladder: racial and gender disparities in survival (1993 to 2002), stage and grade (1993 to 2007). J Urol 2011, 185:1631-1636.
26. Johnson E.K., Daignault S., Zhang Y., Lee C.T. Patterns of hematuria referral to urologists: does a gender disparity exist?. Urology 2008, 72:498-502.
27. Dietrich K., Demidenko E., Schned A., Zens M.S., Heaney J., Karagas M.R. Parity, early menopause and the incidence of bladder cancer in women: a case-control study and meta-analysis. Eur J Cancer 2011, 47:592-599.
28. Davis-Dao C.A., Henderson K.D., Sullivan-Halley J., et al. Lower risk in parous women suggests that hormonal factors are important in bladder cancer etiology. Cancer Epidemiol Biomarkers Prev 2011, 20:1156-1170.
29. Castelao J.E., Yuan J.M., Skipper P.L., et al. Gender- and smoking-related bladder cancer risk. J Natl Cancer Inst 2001, 93:538-545.
30. Mitra A.P., Castelao J.E., Hawes D., et al. Combination of molecular alterations and smoking intensity predicts bladder cancer outcome: a report from the Los Angeles Cancer Surveillance Program. Cancer 2013, 119:756-765.